Editas Medicine, Inc. Contracts & Agreements

73 Contracts & Agreements
Browse by Contract Category
Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Editas Medicine, Inc. Amended and Restated 2015 Stock Incentive Plan
Bonus & Incentive Agreements
Editas Medicine, Inc.
Biotechnology
DE
2025
First Amendment to Second Amended and Restated Collaboration and License Agreement between Editas Medicine, Inc. and Juno Therapeutics, Inc.
Collaboration Agreements
Editas Medicine, Inc.
Biotechnology
NY
2024
Omnibus Amendment to Cas9-I, Cpf1, and Cas9-II License Agreements among Harvard, Broad Institute, and Editas Medicine
Modification Agreements
Editas Medicine, Inc.
Biotechnology
MA
2024
Editas Medicine Non-Employee Director Compensation Program
Compensation Agreements
Editas Medicine, Inc.
Biotechnology
2024
Editas Medicine, Inc. Inducement Restricted Stock Unit Agreement with Participant
Compensation Agreements
Editas Medicine, Inc.
Biotechnology
DE
2024
Editas Medicine, Inc. Inducement Stock Option Agreement with Participant
Warrant Agreements
Editas Medicine, Inc.
Biotechnology
DE
2024
Editas Medicine, Inc. Restricted Stock Unit Agreement under 2015 Stock Incentive Plan
Stock Agreements
Editas Medicine, Inc.
Biotechnology
DE
2024
Editas Medicine, Inc. Restricted Stock Agreement under 2015 Stock Incentive Plan
Stock Agreements
Editas Medicine, Inc.
Biotechnology
DE
2024
Editas Medicine, Inc. Nonstatutory Stock Option Agreement under 2015 Stock Incentive Plan
Warrant Agreements
Editas Medicine, Inc.
Biotechnology
2024
Editas Medicine, Inc. Incentive Stock Option Agreement under 2015 Stock Incentive Plan
Warrant Agreements
Editas Medicine, Inc.
Biotechnology
2024
Description of Editas Medicine, Inc. Common Stock Registered Under Section 12 of the Exchange Act
Equity Distribution Agreements
Editas Medicine, Inc.
Biotechnology
2024
Editas Medicine, Inc. Amended and Restated Severance Benefits Plan
Severance Agreements
Editas Medicine, Inc.
Biotechnology
MA
2023
Separation and Transition Agreement between Editas Medicine, Inc. and Michelle Robertson
Separation Agreements
Editas Medicine, Inc.
Biotechnology
MA
2023
Editas Medicine, Inc. Executive Vice President, Chief Financial Officer Employment Offer Letter to Erick Lucera
Employment Agreements
Editas Medicine, Inc.
Biotechnology
2023
Editas Medicine, Inc. Executive Employment Offer Letter to Linda Burkly, Ph.D.
Employment Agreements
Editas Medicine, Inc.
Biotechnology
2023
Underwriting Agreement between Editas Medicine, Inc. and Underwriters (J.P. Morgan, Cowen, Evercore) for Common Stock Offering
Underwriting Agreements
Editas Medicine, Inc.
Biotechnology
NY
2023
First Amendment to Lease Agreement between ARE-MA Region No. 55, LLC and Editas Medicine, Inc.
Lease Agreements
Editas Medicine, Inc.
Biotechnology
2023
Amendment to Restricted Stock Unit Agreement between Editas Medicine, Inc. and James Mullen
Modification Agreements
Editas Medicine, Inc.
Biotechnology
2022
Editas Medicine, Inc. Employment Offer Letter to Baisong Mei, M.D., Ph.D.
Employment Agreements
Editas Medicine, Inc.
Biotechnology
2022
Amendment to Employment Offer Letter between Editas Medicine, Inc. and James C. Mullen (Executive Chair Transition)
Employment Agreements
Editas Medicine, Inc.
Biotechnology
2022
Editas Medicine, Inc. Employment Offer Letter to Gilmore O’Neill, M.D. (President and CEO)
Employment Agreements
Editas Medicine, Inc.
Biotechnology
2022
Editas Medicine, Inc. Severance Benefits Plan
Severance Agreements
Editas Medicine, Inc.
Biotechnology
MA
2022
Consent and Sublicense Income Acknowledgment Letter between Duke University and Editas Medicine, Inc. regarding Sublicense to Juno Therapeutics
License Agreements
Editas Medicine, Inc.
Biotechnology
2021
Collaboration and License Agreement between Editas Medicine, Inc. and Juno Therapeutics, Inc.
Collaboration Agreements
Editas Medicine, Inc.
Biotechnology
NY
2021
License Agreement between President and Fellows of Harvard College, The Broad Institute, Inc., and Editas Medicine, Inc. (October 29, 2014)
License Agreements
Editas Medicine, Inc.
Biotechnology
MA
2021
License Agreement between Duke University and Editas Medicine, Inc. (October 10, 2014)
License Agreements
Editas Medicine, Inc.
Biotechnology
DE
2021
Second Amendment to Exclusive Patent License Agreement between Editas Medicine, Inc. and The General Hospital Corporation
License Agreements
Editas Medicine, Inc.
Biotechnology
2021
Exclusive Patent License Agreement between The General Hospital Corporation and Editas Medicine, Inc.
License Agreements
Editas Medicine, Inc.
Biotechnology
MA
2021
Editas Medicine, Inc. Promotion Letter for Bruce Eaton as Executive Vice President and Chief Business Officer
Employment Agreements
Editas Medicine, Inc.
Biotechnology
2021
Editas Medicine, Inc. Executive Employment Offer Letter to Dr. Mark Shearman (April 19, 2021)
Employment Agreements
Editas Medicine, Inc.
Biotechnology
2021
Editas Medicine, Inc. Non-Employee Director Compensation Program Summary (Effective June 15, 2021)
Compensation Agreements
Editas Medicine, Inc.
Biotechnology
2021
Common Stock Sales Agreement between Editas Medicine, Inc. and Cowen and Company, LLC (May 14, 2021)
Equity Distribution Agreements
Editas Medicine, Inc.
Biotechnology
NY
2021
Editas Medicine, Inc. Non-Employee Director Compensation Program Summary (Effective February 16, 2021)
Compensation Agreements
Editas Medicine, Inc.
Biotechnology
2021
First Amendment to Sponsored Research Agreement between The Broad Institute, Inc. and Editas Medicine, Inc.
Collaboration Agreements
Editas Medicine, Inc.
Biotechnology
MA
2021
Editas Medicine, Inc. Executive Employment Offer Letter to Lisa A. Michaels, MD
Employment Agreements
Editas Medicine, Inc.
Biotechnology
MA
2021
Omnibus Amendment to Cpf1 and Cas9-II License Agreements between The Broad Institute, Inc. and Editas Medicine, Inc.
Modification Agreements
Editas Medicine, Inc.
Biotechnology
MA
2021
Editas Medicine, Inc. Employment Agreement with James C. Mullen as President and CEO
Employment Agreements
Editas Medicine, Inc.
Biotechnology
2021
Editas Medicine, Inc. and Cynthia Collins Separation and Release Agreement
Separation Agreements
Editas Medicine, Inc.
Biotechnology
MA
2021
Underwriting Agreement for Sale of Common Stock between Editas Medicine, Inc. and Underwriters (J.P. Morgan Securities LLC, Morgan Stanley & Co. LLC)
Underwriting Agreements
Editas Medicine, Inc.
Biotechnology
NY
2021
Termination Agreement between Editas Medicine, Inc. and Allergan Sales, LLC (August 5, 2020)
Termination Agreements
Editas Medicine, Inc.
Biotechnology
NY
2020
Separation and Release Agreement between Editas Medicine, Inc. and Judith R. Abrams
Separation Agreements
Editas Medicine, Inc.
Biotechnology
MA
2020
Advisory Services Agreement between Editas Medicine, Inc. and Judith R. Abrams, M.D.
Advisory Agreements
Editas Medicine, Inc.
Biotechnology
MA
2020
Underwriting Agreement between Editas Medicine, Inc. and Morgan Stanley & Co. LLC for Common Stock Offering
Underwriting Agreements
Editas Medicine, Inc.
Biotechnology
NY
2020
Common Stock Sales Agreement between Editas Medicine, Inc. and Cowen and Company, LLC (May 15, 2020)
Equity Distribution Agreements
Editas Medicine, Inc.
Biotechnology
NY
2020
Letter Agreement Regarding Sublicense Income under License Agreements among Editas Medicine, Inc., The Broad Institute, Inc., and Harvard University
License Agreements
Editas Medicine, Inc.
Biotechnology
2020
Second Amended and Restated Collaboration and License Agreement between Editas Medicine, Inc. and Juno Therapeutics, Inc.
Collaboration Agreements
Editas Medicine, Inc.
Biotechnology
MA
2020
License Agreement between Editas Medicine, Inc. and Juno Therapeutics, Inc. (November 11, 2019)
License Agreements
Editas Medicine, Inc.
Biotechnology
MA
2020
Letter Agreement Regarding Co-Exclusive Target Designation and Royalty Adjustments – Editas Medicine, Inc., Harvard, and Broad Institute
License Agreements
Editas Medicine, Inc.
Biotechnology
2020
Editas Medicine, Inc. Severance Benefits Plan
Severance Agreements
Editas Medicine, Inc.
Biotechnology
MA
2020
Editas Medicine, Inc. Inducement Restricted Stock Unit Agreement with Participant
Compensation Agreements
Editas Medicine, Inc.
Biotechnology
DE
2020
Editas Medicine, Inc. Inducement Stock Option Agreement with Participant
Warrant Agreements
Editas Medicine, Inc.
Biotechnology
DE
2020
Editas Medicine, Inc. Offer of Employment Letter to Michelle Robertson (Chief Financial Officer)
Employment Agreements
Editas Medicine, Inc.
Biotechnology
2020
Editas Medicine, Inc. Offer of Employment Letter to Judith R. Abrams as Chief Medical Officer
Employment Agreements
Editas Medicine, Inc.
Biotechnology
2020
Description of Editas Medicine, Inc. Common Stock Registered Under Section 12 of the Securities Exchange Act of 1934
Equity Distribution Agreements
Editas Medicine, Inc.
Biotechnology
2020
Separation and Release Agreement between Editas Medicine and Vic Myer, Ph.D.
Separation Agreements
Editas Medicine, Inc.
Biotechnology
MA
2019
Editas Medicine, Inc. Employment Offer Letter to Cynthia Collins as President and CEO
Employment Agreements
Editas Medicine, Inc.
Biotechnology
DE
2019
Letter Agreement, dated January 19, 2019, by and between the Registrant and Katrine Bosley
Editas Medicine, Inc.
Biotechnology
MA
2019
Consulting Agreement, dated January 20, 2019, by and between the Registrant and Cynthia Collins
Consulting Agreements
Editas Medicine, Inc.
Biotechnology
MA
2019
Co-Development and Commercialization Agreement between Editas Medicine, Inc. and Allergan Sales, LLC (February 22, 2019)
Collaboration Agreements
Editas Medicine, Inc.
Biotechnology
NY
2019
Separation Agreement, by and between the Registrant and Gerald Cox, M.D., Ph.D
Separation Agreements
Editas Medicine, Inc.
Biotechnology
MA
2019
Form of Restricted Stock Unit Award Agreement under 2015 Stock Incentive Plan
Bonus & Incentive Agreements
Editas Medicine, Inc.
Biotechnology
DE
2019
Collaboration and License Agreement between Editas Medicine, Inc. and Juno Therapeutics, Inc.
License Agreements
Editas Medicine, Inc.
Biotechnology
NY
2018
Sponsored Research Agreement between Broad Institute, Inc. and Editas Medicine, Inc. (June 7, 2018)
Collaboration Agreements
Editas Medicine, Inc.
Biotechnology
MA
2018
Amended and Restated Collaboration and License Agreement between Editas Medicine, Inc. and Juno Therapeutics, Inc.
Collaboration Agreements
Editas Medicine, Inc.
Biotechnology
NY
2018
Underwriting Agreement between Editas Medicine, Inc. and Morgan Stanley & Co. LLC for Common Stock Offering
Underwriting Agreements
Editas Medicine, Inc.
Biotechnology
NY
2017
First Amendment to License Agreement between Editas Medicine, Inc. and Duke University
License Agreements
Editas Medicine, Inc.
Biotechnology
2017
Editas Medicine, Inc. Restricted Stock Agreement under 2015 Stock Incentive Plan
Stock Agreements
Editas Medicine, Inc.
Biotechnology
DE
2017
Underwriting Agreement between Editas Medicine, Inc. and Underwriters (Morgan Stanley & Co. LLC, J.P. Morgan Securities LLC) for 4,000,000 Shares of Common Stock
Underwriting Agreements
Editas Medicine, Inc.
Biotechnology
NY
2017
First Amendment to Exclusive Patent License Agreement between Editas Medicine, Inc. and Massachusetts General Hospital
License Agreements
Editas Medicine, Inc.
Biotechnology
2017
Editas Medicine, Inc. Employment Offer Letter to Gerald F. Cox, M.D., Ph.D. for Chief Medical Officer Position
Employment Agreements
Editas Medicine, Inc.
Biotechnology
2017
Editas Medicine, Inc. Employment Offer Letter to Charles F. Albright, Ph.D.
Employment Agreements
Editas Medicine, Inc.
Biotechnology
2017
Exclusive Patent License Agreement between The General Hospital Corporation and Editas Medicine, Inc.
License Agreements
Editas Medicine, Inc.
Biotechnology
MA
2016
Underwriting Agreement between Editas Medicine, Inc. and Morgan Stanley & Co. LLC and J.P. Morgan Securities LLC (2016)
Underwriting Agreements
Editas Medicine, Inc.
Biotechnology
NY
2016